0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences

Buy Now

Imaging and Multiomic Biomarker Applications (Hardcover) Loot Price: R3,263
Discovery Miles 32 630
Imaging and Multiomic Biomarker Applications (Hardcover): Yongxia Zhou

Imaging and Multiomic Biomarker Applications (Hardcover)

Yongxia Zhou

 (sign in to rate)
Loot Price R3,263 Discovery Miles 32 630 | Repayment Terms: R306 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The well-known Alzheimer's Disease Neuroimaging Initiative (ADNI) Center provides the most advanced, comprehensive, multiparametric and up-to-date biomarkers for mild cognitive impairment (MCI) and early Alzheimer's disease (AD) projects, including neuroimaging, clinical assessments, biospecimens and genetic data. Recent developments in imaging techniques, including new molecular tracers for imaging disease burden and systematic multi-modal integration, have emerged to overcome the limitations of each single modality and individual-dependent variability. The MRI-based high-resolution structural and morphological changes in the brain, such as atrophy, and the abnormal activity/connectivity patterns of the hippocampus subfields and default mode network (DMN) modulation, together with the amyloid and tau neuropathological quantification using PET molecular tracers, could be used to predict brain changes and cognitive performance declines in early AD, including transitional MCI. Finally, a generalized and integrative model with multiple biomarkers could be built to target disease progression and symptom prediction as well as to optimize patient management. Multiomics investigates metabolomic, lipidomic, genomic, transcriptomic and proteomic perspectives by presenting an accurate biochemical profile of the organism in health and disease. The Alzheimer's Disease Metabolomics Consortium (ADMC) in partnership with ADNI is creating a comprehensive biochemical database for patients in the ADNI1 cohort, consisting of eight metabolomics datasets. The vast majorities of biospecimen data provide rich biological information to the human brain at normal and dementia status. One of the purposes is to reveal the connections between disease and multiomics such as obesity, hypertension, cholesterol imbalance and inflammation risks that might lead to neurodegenerative disease. Multiomic biomarker developments in the dementia field have provided earlier clues to novel treatments that help correct metabolic dysfunction and delay disease progression. Furthermore, the assembling of multiomics-based biomarkers including metabolites and lipids, cholesterol biosynthesis, purine metabolism, lipoprotein, bile acids, and genetics as well as their relation to the pathological amyloid and tau network could improve disease diagnosis sensitivity and reveal more diverse and complementary molecular pathways to allow for the advancement of early AD diagnosis and therapeutic prevention. In this book, we report on the significant differences of multiple biomarkers from the ADNI database including neuroimaging, clinical assessments and multiomic biospecimen/genetic data in MCI and early probable AD (pAD), and elucidate the interconnections among different metrics at various domains. Classification results with high accuracies (0.95-1) for each early dementia subtype including early MCI (EMCI), late MCI (LMCI) and pAD, and better prediction of clinical symptoms is achieved with these comprehensive biomarkers. Further longitudinal changes of imaging and neuropsychological biomarkers, and inter-correlations with baseline parameters are examined for a better illustration of disease progression association. Additionally, an analysis of the post-traumatic stress disorder biomarkers is performed with high classification accuracy. With illustrative and rigorous data analyses and confirmative results, this book provides readers with a full spectrum of biomarker research for early dementia diagnosis and treatment, and helps convey the technical development and data evaluation perspectives in advanced medical imaging and various disease application fields.

General

Imprint: nova science publishers
Country of origin: United States
Release date: March 2021
Authors: Yongxia Zhou
Format: Hardcover
Pages: 251
ISBN-13: 978-1-5361-9079-3
Categories: Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
Promotions
LSN: 1-5361-9079-9
Barcode: 9781536190793

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

The Awakened Brain - The Psychology Of…
Lisa Miller Paperback R314 R284 Discovery Miles 2 840
Dystonia, Volume 169
Hyder Jinnah, Kailash Bhatia, … Hardcover R4,500 Discovery Miles 45 000
Encyclopedia of Sleep and Circadian…
Clete Kushida Hardcover R47,916 Discovery Miles 479 160
Introduction to Basic Aspects of the…
Otto Appenzeller, Guillaume J. Lamotte, … Hardcover R3,484 Discovery Miles 34 840
Neurological Complications of Systemic…
Herbert B. Newton, Mark G Malkin Hardcover R5,027 Discovery Miles 50 270
Encyclopedia of Behavioral Neuroscience
Sergio Della Sala Hardcover R47,018 Discovery Miles 470 180
Nanomedicine and Neuroprotection in…
Hari Shanker Sharma, Aruna Sharma Hardcover R6,207 Discovery Miles 62 070
Neurobiology of Bipolar Disorder - Road…
Joao Luciano de Quevedo, Andre Ferrer Carvalho, … Paperback R4,035 Discovery Miles 40 350
What does Medial Frontal Cortex Signal…
Adam Thomas Brockett, Linda M. Amarante, … Hardcover R4,531 Discovery Miles 45 310
Epigenetics, Volume 156
Subhash C. Pandey Hardcover R4,507 Discovery Miles 45 070
The Senses: A Comprehensive Reference
Bernd Fritzsch Hardcover R88,284 Discovery Miles 882 840
Music and the Aging Brain
Lola Cuddy, Sylvie Belleville, … Paperback R3,037 Discovery Miles 30 370

See more

Partners